Compare LNTH & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | NIO |
|---|---|---|
| Founded | 1956 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 12.7B |
| IPO Year | 2014 | 2018 |
| Metric | LNTH | NIO |
|---|---|---|
| Price | $99.65 | $3.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 24 |
| Target Price | ★ $107.74 | $6.30 |
| AVG Volume (30 Days) | 805.3K | ★ 28.1M |
| Earning Date | 11-05-2026 | 09-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | $46.59 |
| Revenue Next Year | $10.29 | $19.07 |
| P/E Ratio | $34.19 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $49.67 | $3.38 |
| 52 Week High | $111.86 | $7.86 |
| Indicator | LNTH | NIO |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 26.74 |
| Support Level | $98.81 | N/A |
| Resistance Level | $101.24 | $3.79 |
| Average True Range (ATR) | 0.40 | 0.08 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 18.97 | 10.98 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations, such as battery swapping and autonomous driving. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 326,000 EVs in 2025, accounting for about 2% of China's passenger new energy vehicle market.